Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vera Therapeutics, Inc. | 2,187,504 | reported | 18 May 2021 | tx 5+2,987,984−2,187,504 |
| CRISPR Therapeutics AG | 1,171,268 | reported | 18 Dec 2018 | tx 58+2,727,748−4,117,139 |
| Vaxcyte, Inc. | 15,000 | reported | 02 Jun 2021 | tx 12+4,223,718−4,196,218 |
| Jasper Therapeutics, Inc. | 7,500 | reported | 03 Jul 2025 | tx 6+170,295−9,075 |
| CymaBay Therapeutics, Inc. | 0 | reported | 22 Mar 2024 | tx 60+402,727−2,195,931 |
| Somaxon Pharmaceuticals, Inc. | 0 | reported | 06 Mar 2013 | tx 47+629,768−288,883 |
| FACET BIOTECH CORP | 0 | reported | 21 Apr 2010 | tx 8+30,001−30,001 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jul 2025 | GRANT_AWARD | Jasper Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Jasper Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 90,000 | — | |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 9,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 15,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 7,500 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 16,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 49,245 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 32,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 67,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 25,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 14,010 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 9,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 9,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 27,705 | — | deriv |
| 24 Jan 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 14,010 | 0.00 USD | deriv |
| 29 Sept 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 15,921 | 5.00 USD | |
| 29 Sept 2023 | SALE | CymaBay Therapeutics, Inc. | 15,921 | 15.68 USD | |
| 29 Sept 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 6,357 | 0.00 USD | deriv |
| 29 Sept 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 5,249 | 0.00 USD | deriv |
| 29 Sept 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 3,372 | 0.00 USD | deriv |
| 29 Sept 2023 | EXERCISE | CymaBay Therapeutics, Inc. | 943 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Jasper Therapeutics, Inc. | 47,000 | 0.00 USD | deriv |
| 13 Apr 2023 | SALE | Jasper Therapeutics, Inc. | 9,075 | 1.49 USD | |
| 25 Jan 2023 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 16 Jun 2020.